IL157073A0 - Therapeutic peptides for demyelinating conditions - Google Patents
Therapeutic peptides for demyelinating conditionsInfo
- Publication number
- IL157073A0 IL157073A0 IL15707302A IL15707302A IL157073A0 IL 157073 A0 IL157073 A0 IL 157073A0 IL 15707302 A IL15707302 A IL 15707302A IL 15707302 A IL15707302 A IL 15707302A IL 157073 A0 IL157073 A0 IL 157073A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic peptides
- demyelinating conditions
- demyelinating
- conditions
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Rehabilitation Therapy (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26356901P | 2001-01-24 | 2001-01-24 | |
PCT/US2002/002071 WO2002059143A2 (en) | 2001-01-24 | 2002-01-24 | Therapeutic peptides for demyelinating conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
IL157073A0 true IL157073A0 (en) | 2004-02-08 |
Family
ID=23002314
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15707302A IL157073A0 (en) | 2001-01-24 | 2002-01-24 | Therapeutic peptides for demyelinating conditions |
IL157073A IL157073A (en) | 2001-01-24 | 2003-07-23 | Therapeutic peptides for demyelinating conditions |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL157073A IL157073A (en) | 2001-01-24 | 2003-07-23 | Therapeutic peptides for demyelinating conditions |
Country Status (4)
Country | Link |
---|---|
US (2) | US6930168B2 (xx) |
AU (1) | AU2002240057A1 (xx) |
IL (2) | IL157073A0 (xx) |
WO (1) | WO2002059143A2 (xx) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002362445B2 (en) | 2001-10-03 | 2006-09-21 | President And Fellows Of Harvard College | Copolymers for suppression of autoimmune diseases, and methods of use |
WO2005030955A1 (ja) * | 2003-09-29 | 2005-04-07 | Chugai Seiyaku Kabushiki Kaisha | Nk細胞に発現するタンパク質 |
CA2540890A1 (en) * | 2003-10-03 | 2005-04-14 | Bayhill Therapeutics, Inc. | Treatment of demyelinating autoimmune disease with modified ordered peptides |
CA2548310C (en) * | 2003-12-09 | 2014-02-18 | Yeda Research And Development Co. Ltd. | Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
EP1725099A4 (en) * | 2004-02-02 | 2009-08-19 | Mixture Sciences Inc | MIXTURES OF PEPTIDES WITH IMMUNOMODULATORY ACTIVITY |
BRPI0510738A (pt) | 2004-05-07 | 2007-11-20 | Peptimmune Inc | métodos de tratar doenças com copolìmeros aleatórios |
US20070264229A1 (en) * | 2004-09-13 | 2007-11-15 | Strominger Jack L | Peptides for Treatment of Autoimmune Disease |
WO2006031727A2 (en) * | 2004-09-13 | 2006-03-23 | President And Fellows Of Harvard College | Peptides for treatment of autoimmune diseases |
AU2005302500B2 (en) * | 2004-10-29 | 2008-11-27 | Sandoz Ag | Processes for preparing glatiramer |
WO2007075335A2 (en) * | 2005-12-16 | 2007-07-05 | The Regents Of The University Of California | Modulation of in utero immune programming |
US8961982B2 (en) * | 2005-12-16 | 2015-02-24 | The Regents Of The University Of California | Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer |
AU2007238595A1 (en) * | 2006-04-13 | 2007-10-25 | Peptimmune, Inc. | Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability |
US20090036653A1 (en) * | 2006-04-13 | 2009-02-05 | Peptimmune, Inc. | Methods for the directed expansion of epitopes for use as antibody ligands |
US7626279B2 (en) * | 2007-01-08 | 2009-12-01 | Veryst Engineering Llc | Method and apparatus for energy harvesting using rotational energy storage and release |
BRPI0811293A2 (pt) * | 2007-05-07 | 2017-05-16 | Peptimmune Inc | métodos para a expansão direta de epítopos para uso com ligantes de anticorpo. |
BRPI0817682A2 (pt) | 2007-10-16 | 2015-04-07 | Peptimmune Inc | Métodos para projetar e preparar vacinas compreendendo composições de polímero de sequência direcionada via a expansão direta de epítopos |
IT1391939B1 (it) * | 2008-11-12 | 2012-02-02 | Rolic Invest Sarl | Generatore eolico |
JP2013511725A (ja) * | 2009-11-17 | 2013-04-04 | アレス トレーディング ソシエテ アノニム | 血清タンパク質に基づくランダム配列ポリマー組成物の検出による、ランダム配列ポリマー組成物の設計、生物学的利用性、及び有効性を改良するための方法 |
WO2012150495A1 (en) | 2011-05-05 | 2012-11-08 | National Institute Of Immunology | Synthetic peptides and random copolymers for the treatment of autoimmune disorders |
WO2013148372A1 (en) * | 2012-03-30 | 2013-10-03 | President And Fellows Of Harvard College | Methods for amelioration of autoimmune disease using stem cells transduced with t cell receptors from il-10 secreting t cells |
US20220275051A1 (en) * | 2019-07-30 | 2022-09-01 | University Health Network | Mhc class ii molecules and methods of use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614192A (en) * | 1989-07-19 | 1997-03-25 | Connective Therapeutics, Inc. | T cell receptor peptides as therapeutics for immune-related disease |
CA2142007C (en) * | 1992-08-11 | 2007-10-30 | Robert Glen Urban | Immunomodulatory peptides |
US6696061B1 (en) * | 1992-08-11 | 2004-02-24 | President And Fellows Of Harvard College | Immunomodulatory peptides |
WO2002057291A2 (en) * | 2000-12-12 | 2002-07-25 | Corixa Corporation | Hla-dr2 binding peptides |
AU2002362445B2 (en) * | 2001-10-03 | 2006-09-21 | President And Fellows Of Harvard College | Copolymers for suppression of autoimmune diseases, and methods of use |
-
2002
- 2002-01-24 AU AU2002240057A patent/AU2002240057A1/en not_active Abandoned
- 2002-01-24 US US10/056,583 patent/US6930168B2/en not_active Expired - Fee Related
- 2002-01-24 WO PCT/US2002/002071 patent/WO2002059143A2/en not_active Application Discontinuation
- 2002-01-24 IL IL15707302A patent/IL157073A0/xx unknown
-
2003
- 2003-07-23 IL IL157073A patent/IL157073A/en not_active IP Right Cessation
-
2005
- 2005-06-10 US US11/150,755 patent/US7456252B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6930168B2 (en) | 2005-08-16 |
IL157073A (en) | 2008-12-29 |
US7456252B2 (en) | 2008-11-25 |
WO2002059143A2 (en) | 2002-08-01 |
US20030064915A1 (en) | 2003-04-03 |
US20060020109A1 (en) | 2006-01-26 |
WO2002059143A3 (en) | 2004-01-22 |
AU2002240057A1 (en) | 2002-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL157073A0 (en) | Therapeutic peptides for demyelinating conditions | |
IL159310A0 (en) | Peptide-based compounds | |
AU5943201A (en) | Modified peptides as therapeutic agents | |
EP1463438A4 (en) | ENDOMURAL THERAPY | |
EP1429796A4 (en) | ANTIANGIOGENIC DRUGS BASED ON PEPTIDES | |
IL157944A0 (en) | Hormone replacement therapy | |
GB0118383D0 (en) | Therapeutic methods | |
AU2003290563A8 (en) | Leptin-related peptides | |
GB0101225D0 (en) | Pharmaceutical compounds | |
GB0101227D0 (en) | Pharmaceutical compounds | |
AU2001259837A1 (en) | Therapeutic pore-forming peptides | |
EP1391518A4 (en) | PROCESS FOR PEPTIDE MANUFACTURE | |
GB0100196D0 (en) | Peptides | |
SG120874A1 (en) | Process for the preparation of peptides | |
SI1392722T1 (sl) | Postopek za pripravo ehinokandina | |
GB0101933D0 (en) | Therapy | |
GB0116047D0 (en) | Peptide motif for therapy | |
AU5836700A (en) | Peptides for therapeutic use | |
PL366425A1 (en) | Peptide compounds | |
IL150458A0 (en) | Novel haptotactic peptides | |
GB0109438D0 (en) | Peptides | |
GB0113705D0 (en) | Therapeutic peptides | |
GB0125372D0 (en) | Modified peptides | |
GB0117737D0 (en) | Modified peptides | |
GB9901506D0 (en) | Therapeutic peptides |